Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)

NCT04543994 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped PI left Cleveland Clinic

Conditions

Ulcerative Colitis

Interventions

DRUG: Remestemcel-L
DRUG: Remestemcel-L
OTHER: Placebo

Sponsor

The Cleveland Clinic

Collaborators

[object Object]